BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 19062319)

  • 1. The zinc finger transcription factor Zbtb7b represses CD8-lineage gene expression in peripheral CD4+ T cells.
    Wang L; Wildt KF; Castro E; Xiong Y; Feigenbaum L; Tessarollo L; Bosselut R
    Immunity; 2008 Dec; 29(6):876-87. PubMed ID: 19062319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcription factor Zbtb7b promotes CD4 expression by antagonizing Runx-mediated activation of the CD4 silencer.
    Wildt KF; Sun G; Grueter B; Fischer M; Zamisch M; Ehlers M; Bosselut R
    J Immunol; 2007 Oct; 179(7):4405-14. PubMed ID: 17878336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells.
    Grueter B; Petter M; Egawa T; Laule-Kilian K; Aldrian CJ; Wuerch A; Ludwig Y; Fukuyama H; Wardemann H; Waldschuetz R; Möröy T; Taniuchi I; Steimle V; Littman DR; Ehlers M
    J Immunol; 2005 Aug; 175(3):1694-705. PubMed ID: 16034110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAZR and Runx Factors Synergistically Repress ThPOK during CD8+ T Cell Lineage Development.
    Sakaguchi S; Hainberger D; Tizian C; Tanaka H; Okuda T; Taniuchi I; Ellmeier W
    J Immunol; 2015 Sep; 195(6):2879-87. PubMed ID: 26254341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A ThPOK-LRF transcriptional node maintains the integrity and effector potential of post-thymic CD4+ T cells.
    Vacchio MS; Wang L; Bouladoux N; Carpenter AC; Xiong Y; Williams LC; Wohlfert E; Song KD; Belkaid Y; Love PE; Bosselut R
    Nat Immunol; 2014 Oct; 15(10):947-56. PubMed ID: 25129370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the Runx3 transcription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage.
    Kohu K; Sato T; Ohno S; Hayashi K; Uchino R; Abe N; Nakazato M; Yoshida N; Kikuchi T; Iwakura Y; Inoue Y; Watanabe T; Habu S; Satake M
    J Immunol; 2005 Mar; 174(5):2627-36. PubMed ID: 15728469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ikaros null mice display defects in T cell selection and CD4 versus CD8 lineage decisions.
    Urban JA; Winandy S
    J Immunol; 2004 Oct; 173(7):4470-8. PubMed ID: 15383578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thpok-independent repression of Runx3 by Gata3 during CD4+ T-cell differentiation in the thymus.
    Xiong Y; Castro E; Yagi R; Zhu J; Lesourne R; Love PE; Feigenbaum L; Bosselut R
    Eur J Immunol; 2013 Apr; 43(4):918-28. PubMed ID: 23310955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4-CD8 lineage differentiation: Thpok-ing into the nucleus.
    Wang L; Bosselut R
    J Immunol; 2009 Sep; 183(5):2903-10. PubMed ID: 19696430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the transcription factor cKrox in peripheral CD8 T cells reveals substantial postthymic plasticity in CD4-CD8 lineage differentiation.
    Jenkinson SR; Intlekofer AM; Sun G; Feigenbaum L; Reiner SL; Bosselut R
    J Exp Med; 2007 Feb; 204(2):267-72. PubMed ID: 17296789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZBTB7B (Th-POK) regulates the development of IL-17-producing CD1d-restricted mouse NKT cells.
    Enders A; Stankovic S; Teh C; Uldrich AP; Yabas M; Juelich T; Altin JA; Frankenreiter S; Bergmann H; Roots CM; Kyparissoudis K; Goodnow CC; Godfrey DI
    J Immunol; 2012 Dec; 189(11):5240-9. PubMed ID: 23105140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morpholino antisense oligonucleotide-mediated gene knockdown during thymocyte development reveals role for Runx3 transcription factor in CD4 silencing during development of CD4-/CD8+ thymocytes.
    Ehlers M; Laule-Kilian K; Petter M; Aldrian CJ; Grueter B; Würch A; Yoshida N; Watanabe T; Satake M; Steimle V
    J Immunol; 2003 Oct; 171(7):3594-604. PubMed ID: 14500656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The zinc-finger protein MAZR is part of the transcription factor network that controls the CD4 versus CD8 lineage fate of double-positive thymocytes.
    Sakaguchi S; Hombauer M; Bilic I; Naoe Y; Schebesta A; Taniuchi I; Ellmeier W
    Nat Immunol; 2010 May; 11(5):442-8. PubMed ID: 20383150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl11b represses a mature T-cell gene expression program in immature CD4(+)CD8(+) thymocytes.
    Kastner P; Chan S; Vogel WK; Zhang LJ; Topark-Ngarm A; Golonzhka O; Jost B; Le Gras S; Gross MK; Leid M
    Eur J Immunol; 2010 Aug; 40(8):2143-54. PubMed ID: 20544728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyzing expression of perforin, Runx3, and Thpok genes during positive selection reveals activation of CD8-differentiation programs by MHC II-signaled thymocytes.
    Liu X; Taylor BJ; Sun G; Bosselut R
    J Immunol; 2005 Oct; 175(7):4465-74. PubMed ID: 16177089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-positive selection of thymocytes expressing a single TCR by multiple major histocompatibility complex molecules of both classes: implications for CD4+ versus CD8+ lineage commitment.
    Eshima K; Suzuki H; Shinohara N
    J Immunol; 2006 Feb; 176(3):1628-36. PubMed ID: 16424192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-regulatory factors during development of CD4 and CD8 thymocytes.
    Simon AK; Desrois M; Schmitt-Verhulst AM
    Immunology; 1997 Jul; 91(3):340-5. PubMed ID: 9301521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enigma of CD4-lineage specification.
    Xiong Y; Bosselut R
    Eur J Immunol; 2011 Mar; 41(3):568-74. PubMed ID: 21341258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Fateful Decision in the Thymus Controlled by the Transcription Factor ThPOK.
    Egawa T
    J Immunol; 2021 May; 206(9):1981-1982. PubMed ID: 33879577
    [No Abstract]   [Full Text] [Related]  

  • 20. Reciprocal control of G1-phase progression is required for Th-POK/Runx3-mediated CD4/8 thymocyte cell fate decision.
    Sato T; Chiba T; Ohno S; Sato C; Sugoh T; Miyashita K; Akatsuka H; Hozumi K; Okada Y; Iida Y; Akatsuka A; Agata Y; Chiba M; Kohu K; Satake M; Tanabe H; Saya H; Habu S
    J Immunol; 2012 Nov; 189(9):4426-36. PubMed ID: 23018457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.